CDNA CareDx, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 5, 2026 10-K/10-Q Jul 30, 2026
$68.58
· of 52w range
· above low
· to high
$13.9552w low
$69.8052w high
Market Cap (MRQ)
$3.53B
P/E (TTM)
33.1
EPS (TTM)
$2.07
Revenue (TTM)
$458M
your badges
52W Range
$14–$70
Analyst Rating
STRONG BUY
Price Target
$59
P/E
33.1
ROE
29.5%
Net Profit Margin
24.2%
Your badge strip is empty — pin a metric anywhere on this page.
CDNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$68.58
Market Cap (MRQ)
$3.53B
P/E (TTM)
33.1
EPS (TTM)
$2.07
Revenue (TTM)
$458M
ROE (TTM)
29.5%
52W Range
$14–$70
CDNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About CareDx, Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees761
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$380M2017-12-31 → 2025-12-31
EPS$-0.402017-12-31 → 2025-12-31
Free Cash Flow·2017-12-31 → 2018-12-31
Net margin24.2%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CDNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 33.15Y avg ≈-22.5 | ≈-22.5 | 27.9 | Undervalued | |
| P/S (TTM) | 7.75Y avg ≈3.7 | ≈3.7 | 11.9 | Undervalued | |
| P/B (MRQ) | 8.35Y avg ≈3.0 | ≈3.0 | 4.2 | Undervalued | |
| Price / Cash Flow | 83.75Y avg ≈-25.8 | ≈-25.8 | · | · | |
| Price / Tangible Book (MRQ) | 8.75Y avg ≈3.9 | ≈3.9 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CDNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 23.6%5Y avg ≈-20.5% | ≈-20.5% | 12.5% | Top tier | |
| EBITDA Margin (TTM) | 26.8%5Y avg ≈-17.8% | ≈-17.8% | 12.5% | Top tier | |
| Pretax Margin (TTM) | 25.1%5Y avg ≈-18.4% | ≈-18.4% | 16.4% | Top tier | |
| Net Profit Margin (TTM) | 24.2%5Y avg ≈-18.4% | ≈-18.4% | 10.2% | Top tier | |
| ROA (TTM) | 22.7%5Y avg ≈-10.4% | ≈-10.4% | -13.8% | Top tier | |
| ROE (TTM) | 29.5%5Y avg ≈-14.5% | ≈-14.5% | -10.7% | Top tier | |
| ROIC | -10.3%5Y avg ≈-20.3% | ≈-20.3% | -12.3% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CDNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.65Y avg ≈4.3 | ≈4.3 | 4.6 | In line | |
| Quick Ratio (MRQ) | 4.45Y avg ≈4.0 | ≈4.0 | 4.1 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CDNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 13.8%5Y avg ≈16.6% | ≈16.6% | · | · | |
| Revenue CAGR 3Y | 5.7%5Y avg ≈7.7% | ≈7.7% | · | · | |
| Revenue CAGR 5Y | 14.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CDNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.7 | ≈0.7 | 0.4 | Top tier | |
| Receivables Turnover | 7.15Y avg ≈5.8 | ≈5.8 | 8.4 | Below avg | |
| Revenue / Employee | ≈$499.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
44.4%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 4, 2026 | $0.37 | $0.24 | 55.8% |
| March 31, 2026 | $0.34 | $0.14 | 149.6% | |
| Dec. 31, 2025 | $0.12 | $0.24 | -50.8% | |
| Sept. 30, 2025 | $0.28 | $0.14 | 93.8% | |
| June 30, 2025 | $0.10 | $0.12 | -18.1% | |
| March 31, 2025 | $0.09 | $0.07 | 36.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Cost of Revenue | · | · | · | · | · | · | $45M | $33M | $21M | $10M | $0 | $0 | |
| Gross Profit | · | · | · | · | · | · | $82M | $44M | $27M | · | · | · | |
| R&D Expense | $71M | $73M | $82M | $90M | $77M | $49M | $31M | $15M | $12M | $12M | $9M | $4M | |
| SG&A Expense | $108M | $125M | $119M | $100M | $75M | $49M | $37M | $23M | $20M | $21M | $12M | $8M | |
| Operating Expenses | $411M | $293M | $484M | $399M | $326M | $215M | $152M | $92M | $47M | $78M | $40M | $26M | |
| Operating Income | $-31M | $41M | $-203M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | $-37M | $-12M | $1M | |
| Other Non-op | $524.0K | $329.0K | $1M | $-3M | $-3M | $-811.0K | $-719.0K | $-178.0K | $-1M | $-2M | $-188.0K | $-78.0K | |
| Pretax Income | $-21M | $53M | $-190M | $-76M | $-32M | $-20M | $-24M | $-48M | $-57M | $-41M | $-14M | $-719.0K | |
| Income Tax | $271.0K | $310.0K | $141.0K | $379.0K | $-1M | $-1M | $-2M | $-1M | $-2M | $-2M | $0 | $-2M | |
| Net Income | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| EPS (Basic) | $-0.40 | $1.00 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.13 | |
| EPS (Diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 | |
| Shares (Basic) | 53,287,546 | 52,773,247 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 5,815,928 | |
| Shares (Diluted) | 53,287,546 | 56,620,590 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 9,283,001 | |
| EBITDA | $-16M | $55M | $-189M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | · | · | $2M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $115M | $82M | $90M | $348M | $135M | $38M | $65M | $17M | $17M | $30M | $36M | |
| Short-term Investments | $112M | $146M | $153M | $203M | $0 | $90M | $0 | · | · | · | · | · | |
| Receivables | $43M | $65M | $51M | $66M | $60M | $35M | $24M | $10M | $3M | $3M | · | · | |
| Inventory | $27M | $20M | $19M | $19M | $17M | $10M | $6M | $5M | $6M | $5M | $766.0K | $686.0K | |
| Prepaid Expense | $11M | $7M | $8M | $9M | $8M | $4M | $4M | $2M | $1M | $1M | $1M | $542.0K | |
| Current Assets | $257M | $352M | $314M | $388M | $433M | $273M | $72M | $81M | $27M | $27M | $34M | $40M | |
| PP&E (Net) | $33M | $34M | $35M | $36M | $22M | $11M | $4M | $4M | $2M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $18M | $18M | $17M | $14M | $13M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $14M | $15M | $14M | $12M | $11M | |
| Goodwill | $40M | $40M | $40M | $38M | $37M | $24M | $24M | $12M | $12M | $14M | $12M | $12M | |
| Intangibles | $32M | $38M | $46M | $43M | $50M | $44M | $46M | $33M | $33M | $33M | $7M | $7M | |
| Other Non-current Assets | $3M | $2M | $1M | $4M | $6M | $1M | $1M | $0 | $0 | $20.0K | $49.0K | $25.0K | |
| Total Assets | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Accounts Payable | $10M | $8M | $13M | $10M | $13M | $10M | $6M | $5M | $3M | $3M | $2M | $1M | |
| Current Liabilities | $90M | $89M | $78M | $76M | $77M | $69M | $35M | $20M | $43M | $41M | $10M | $11M | |
| Capital Leases | $20M | $22M | $28M | $33M | $17M | $16M | $2M | $249.0K | $14.0K | $26.0K | $57.0K | $106.0K | |
| Deferred Tax | $181.0K | $164.0K | $136.0K | $0 | $415.0K | $1M | $2M | $3M | $5M | $6M | $0 | · | |
| Other Non-current Liabilities | $418.0K | $645.0K | $97M | $249.0K | $455.0K | $240.0K | $2M | $2M | $1M | $1M | $28.0K | $28.0K | |
| Total Liabilities | $110M | $113M | $205M | $112M | $101M | $91M | $53M | $35M | $90M | $57M | $26M | $20M | |
| Long-term Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | $24M | $16M | $11M | |
| Total Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | · | · | $11M | |
| Common Stock | $50.0K | $51.0K | $49.0K | $52.0K | $52.0K | $49.0K | $42.0K | $41.0K | $29.0K | $21.0K | $12.0K | $12.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $236M | $203M | $201M | |
| Retained Earnings | $-619M | $-626M | $-678M | $-460M | $-383M | $-353M | $-334M | $-312M | $-268M | $-213M | $-173M | $-159M | |
| AOCI | $-6M | $-9M | $-7M | $-8M | $-5M | $-2M | $-5M | $-4M | $-2M | $-4M | $0 | · | |
| Stockholders' Equity | $303M | $378M | $261M | $431M | $466M | $278M | $99M | $96M | $-6M | $19M | $29M | $41M | |
| Liabilities + Equity | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Shares Outstanding | 50,916,644 | 54,771,203 | 51,503,377 | 53,533,250 | 52,923,360 | 49,441,166 | 42,498,430 | 41,384,960 | 28,825,019 | 21,278,373 | 11,902,363 | 11,803,970 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $14M | $12M | $9M | $7M | $6M | $4M | $4M | $3M | $796.0K | $512.0K | |
| Stock-based Comp | $35M | $66M | $49M | $47M | $36M | $23M | $22M | $7M | $2M | $2M | $1M | $535.0K | |
| Deferred Tax | $-149.0K | $101.0K | $72.0K | $-278.0K | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $0 | $-2M | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $4M | $2M | $3M | $2M | $0 | · | |
| Restructuring | · | $2M | $2M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $14M | $-95M | $108M | · | · | · | · | · | · | · | · | $-5M | |
| Operating Cash Flow | $42M | $38M | $-18M | $-25M | $-19M | $33M | $-3M | $-4M | $-14M | $-17M | $-10M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $2M | $186.0K | $549.0K | $1M | $733.0K | |
| Investing Cash Flow | $2M | $-483.0K | $40M | $-229M | $48M | $-100M | $-23M | $-8M | $-6M | $-21M | · | · | |
| Stock Issued | · | · | $0 | $0 | $189M | · | · | · | · | · | · | · | |
| Stock Repurchased | $88M | $522.0K | $28M | $642.0K | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-88M | $-522.0K | $-28M | $-642.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-93M | $-6M | $-30M | $-5M | $186M | $163M | $-132.0K | $50M | $29M | $25M | · | · | |
| Net Change in Cash | $-49M | $32M | $-8M | $-258M | $214M | $96M | $-26M | $38M | $9M | $-13M | $-7M | $31M | |
| Taxes Paid | $284.0K | $317.0K | $738.0K | $392.0K | $14.0K | $80.0K | $0 | $0 | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $-6M | $-14M | · | · | $-4M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 64.2% | · | · | · | · | · | |
| Operating Margin | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 4.6% | |
| Net Margin | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -114.8% | · | · | 2.9% | |
| Pretax Margin | -5.5% | 15.8% | -67.8% | -23.7% | -10.8% | -10.3% | -18.9% | -63.0% | -118.5% | · | · | -2.6% | |
| EBITDA Margin | -4.2% | 16.5% | -67.4% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 6.5% | |
| ROA | -4.7% | 11.0% | -37.7% | -13.8% | -6.6% | -7.2% | -15.6% | -43.6% | -69.9% | · | · | 2.2% | |
| ROE | -6.8% | 16.1% | -58.1% | -17.1% | -6.5% | -6.9% | -22.4% | -104.1% | -831.1% | · | · | -1.4% | |
| ROIC | -10.3% | 10.7% | -77.9% | -18.0% | -6.1% | -7.7% | -22.7% | -15.8% | -70.5% | · | · | -2.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 | 3.9 | 2.1 | 4.2 | 0.6 | · | · | 3.6 | |
| Quick Ratio | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 | 3.7 | 1.8 | 3.8 | 0.5 | · | · | 3.3 | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -5.6 | · | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -3.0 | · | · | 0.1 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.9 | 0.7 | 0.6 | · | · | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | 8.3 | · | 1.6 | · | · | 14.2 | |
| Receivables Turnover | 7.1 | 5.8 | 4.8 | 5.1 | 6.3 | 6.6 | 7.5 | 12.0 | 16.8 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.95 | $6.91 | $5.07 | $8.05 | $8.80 | $5.62 | $2.33 | $2.32 | $-0.21 | · | · | $3.50 | |
| Revenue / Share | $7.13 | $5.90 | $5.21 | $6.03 | $5.67 | $4.13 | $3.01 | $2.15 | $2.07 | · | · | $2.94 | |
| Cash Flow / Share | $0.79 | $0.67 | $-0.34 | $-0.47 | $-0.37 | $0.72 | $-0.07 | $-0.11 | $-0.61 | · | · | $-0.36 | |
| Cash / Share | $1.28 | $2.09 | $1.60 | $1.68 | $6.58 | $2.72 | $0.90 | $1.56 | $0.59 | · | · | $3.09 | |
| EPS (TTM) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.7% | 4.0% | 13.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Net Income TTM | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| Market Cap | $959M | $1.17B | $618M | $611M | $2.41B | $3.58B | $917M | $1.04B | $212M | · | · | $86M | |
| Enterprise Value | · | · | · | · | · | $3.36B | $878M | $976M | $229M | · | · | $61M | |
| P/E | -47.1 | 23.0 | -3.4 | -7.9 | -77.1 | -181.1 | -41.5 | -19.2 | -3.1 | -1.1 | -5.5 | 72.5 | |
| P/S | 2.5 | 3.5 | 2.2 | 1.9 | 8.1 | 18.6 | 7.2 | 13.6 | 4.4 | · | · | 3.1 | |
| P/B | 3.2 | 3.1 | 2.4 | 1.4 | 5.2 | 12.9 | 9.3 | 10.8 | -34.5 | · | · | 2.1 | |
| P / Tangible Book | 4.2 | 3.9 | 3.5 | 1.7 | 6.4 | 17.1 | · | · | · | · | · | · | |
| P / Cash Flow | 22.8 | 30.8 | -33.6 | -24.2 | -124.8 | 107.1 | -331.1 | -259.7 | -14.8 | · | · | -25.5 | |
| P / FCF | · | · | · | · | · | · | · | -172.2 | -14.6 | · | · | -21.0 | |
| EV / EBITDA | · | · | · | · | · | -149.0 | -35.8 | -62.6 | -11.3 | · | · | 34.4 | |
| EV / FCF | · | · | · | · | · | · | · | -161.5 | -15.8 | · | · | -14.8 | |
| EV / Revenue | · | · | · | · | · | 17.5 | 6.9 | 12.7 | 4.7 | · | · | 2.2 | |
| Earnings Yield | -2.1% | 4.3% | -29.5% | -12.6% | -1.3% | -0.55% | -2.4% | -5.2% | -32.4% | -88.5% | -18.1% | 1.4% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $132M | $118M | $108M | $100M | $87M | $85M | $87M | $83M | $92M | $72M | $66M | $67M | $70M | $77M | $82M | $79M | |
| R&D Expense | $22M | $21M | $19M | $17M | $17M | $19M | $17M | $17M | $20M | $19M | $19M | $19M | $20M | $24M | $24M | $22M | |
| SG&A Expense | $41M | $30M | $29M | $28M | $28M | $23M | $32M | $32M | $31M | $30M | $28M | $34M | $29M | $28M | $25M | $24M | |
| Operating Expenses | $19M | $117M | $114M | $100M | $98M | $98M | $2M | $97M | $100M | $95M | $188M | $96M | $98M | $102M | $102M | $97M | |
| Operating Income | $113M | $1M | $-6M | $-246.0K | $-11M | $-13M | $84M | $-14M | $-7M | $-23M | $-123M | $-29M | $-28M | $-24M | $-19M | $-17M | |
| Other Non-op | $-440.0K | $-330.0K | $264.0K | $-107.0K | $72.0K | $295.0K | $436.0K | $283.0K | $-100.0K | $-290.0K | $2M | $2M | $-271.0K | $-2M | $-924.0K | $-572.0K | |
| Pretax Income | $115M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-10M | $-5M | $-20M | $-118M | $-24M | $-25M | $-24M | $-18M | $-17M | |
| Income Tax | $4M | $-32.0K | $345.0K | $-15.0K | $-117.0K | $58.0K | $171.0K | $200.0K | $22.0K | $-83.0K | $165.0K | $-80.0K | $-68.0K | $124.0K | $173.0K | $267.0K | |
| Net Income | $111M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-11M | $-5M | $-20M | $-118M | $-23M | $-25M | $-24M | $-18M | $-17M | |
| EPS (Basic) | $2.15 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.67 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| EPS (Diluted) | $2.07 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.60 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| Shares (Basic) | 51,469,375 | 51,151,794 | · | 52,507,582 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| Shares (Diluted) | 53,422,523 | 53,129,928 | · | 53,736,790 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| EBITDA | $113M | $5M | · | $-246.0K | $-11M | $-10M | · | $-10M | $-4M | $-16M | · | $-29M | $-28M | $-21M | · | $-17M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $374M | $78M | $65M | $91M | $68M | $89M | $115M | $95M | $96M | $93M | $82M | $76M | $88M | $75M | $90M | $83M | |
| Short-term Investments | $0 | $109M | $112M | $103M | $118M | $142M | $146M | $145M | $133M | $123M | · | $192M | $195M | $211M | · | $208M | |
| Receivables | $34M | $45M | $43M | $48M | $67M | $71M | $65M | $67M | $66M | $60M | · | $52M | $52M | $59M | · | $70M | |
| Inventory | $7M | $26M | $27M | $28M | $28M | $23M | $20M | $19M | $19M | $20M | · | $18M | $19M | $18M | · | $18M | |
| Prepaid Expense | $14M | $11M | $11M | $30M | $26M | $25M | $7M | $7M | $6M | $7M | · | $7M | $8M | $8M | · | $8M | |
| Current Assets | $429M | $269M | $257M | $300M | $307M | $350M | $352M | $334M | $321M | $303M | · | $345M | $361M | $371M | · | $388M | |
| PP&E (Net) | $27M | $33M | $33M | $31M | $32M | $33M | $34M | $34M | $34M | $34M | · | $35M | $36M | $36M | · | $34M | |
| Goodwill | $36M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | · | $40M | $40M | $40M | $38M | $38M | |
| Intangibles | $19M | $32M | $32M | $33M | $36M | $37M | $38M | $40M | $42M | $43M | · | $46M | $44M | $46M | · | $44M | |
| Other Non-current Assets | $6M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $5M | |
| Total Assets | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Accounts Payable | $9M | $9M | $10M | $12M | $10M | $8M | $8M | $6M | $6M | $10M | · | $9M | $10M | $13M | · | $11M | |
| Current Liabilities | $94M | $79M | $90M | $99M | $93M | $85M | $89M | $81M | $78M | $70M | · | $73M | $74M | $72M | · | $70M | |
| Capital Leases | $13M | $18M | $20M | $21M | $23M | $24M | $22M | $24M | $25M | $27M | · | $29M | $31M | $32M | · | $35M | |
| Deferred Tax | $86.0K | $130.0K | $181.0K | $117.0K | $131.0K | $129.0K | $164.0K | $202.0K | $50.0K | $43.0K | · | $140.0K | $51.0K | · | · | $13.0K | |
| Other Non-current Liabilities | $406.0K | $407.0K | $257.0K | $634.0K | $636.0K | $644.0K | $645.0K | $97M | $97M | $98M | · | $245.0K | $247.0K | $248.0K | · | $251.0K | |
| Total Liabilities | $107M | $98M | $110M | $121M | $117M | $110M | $113M | $204M | $202M | $196M | · | $107M | $110M | $108M | · | $108M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Common Stock | $51.0K | $51.0K | $50.0K | $51.0K | $53.0K | $51.0K | $51.0K | $50.0K | $50.0K | $49.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | |
| Retained Earnings | $-505M | $-733M | $-735M | $-719M | $-695M | $-637M | $-626M | $-704M | $-697M | $-695M | · | $-534M | $-510M | $-485M | · | $-441M | |
| AOCI | $0 | $-6M | $-6M | $-6M | $-6M | $-7M | $-9M | $-7M | $-8M | $-8M | · | $-9M | $-8M | $-7M | · | $-9M | |
| Stockholders' Equity | $426M | $314M | $303M | $311M | $327M | $379M | $378M | $273M | $265M | $256M | $261M | $394M | $405M | $420M | $431M | $437M | |
| Liabilities + Equity | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Shares Outstanding | 51,482,536 | 51,274,651 | 50,916,644 | 51,407,335 | 53,220,123 | 55,462,730 | 54,771,203 | 53,106,871 | 52,617,443 | 51,782,612 | 51,503,377 | 54,153,496 | 54,013,601 | 53,653,182 | 53,533,250 | 53,523,453 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Stock-based Comp | $11M | $10M | $8M | $8M | $9M | $9M | $17M | $23M | $20M | $17M | $10M | $13M | $13M | $14M | $12M | $11M | |
| Amort. of Intangibles | $529.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | $0 | $68.0K | · | · | $0 | $848.0K | $60.0K | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-29M | · | · | · | $-16M | · | · | · | $7M | · | · | |
| Operating Cash Flow | $31M | $4M | $21M | $37M | $10M | $-27M | $22M | $13M | $19M | $-15M | $-8M | $-10M | $-499.0K | $671.0K | $7M | $-7M | |
| CapEx | $2M | $4M | · | · | $1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $281M | $11M | $-35M | $12M | $23M | $1M | $-2M | $-14M | $-12M | $28M | $41M | $-1M | $15M | $-15M | $2M | $-76M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | · | · | $12M | $26M | $50M | $0 | $0 | $0 | $0 | $522.0K | $26M | $814.0K | $67.0K | $690.0K | $642.0K | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-522.0K | · | · | · | $-690.0K | · | · | |
| Financing Cash Flow | $-15M | $-3M | $-12M | $-26M | $-54M | $-643.0K | $-903.0K | $1M | $-5M | $-1M | $-27M | $-25.0K | $-2M | $-1M | $-2M | $-1M | |
| Net Change in Cash | $296M | $12M | $-26M | $23M | $-21M | $-26M | $19M | $-378.0K | $2M | $11M | $6M | $-12M | $13M | $-15M | $7M | $-84M | |
| Free Cash Flow | · | $514.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 85.8% | 1.0% | · | -0.25% | -12.8% | -15.8% | · | -12.7% | -4.4% | -26.8% | · | -42.8% | -39.3% | -31.5% | · | -21.9% | |
| Net Margin | 83.9% | 2.4% | · | 1.7% | -9.9% | -12.2% | · | -8.9% | -1.5% | -23.1% | · | -34.9% | -35.5% | -30.7% | · | -21.3% | |
| Pretax Margin | 86.8% | 2.4% | · | 1.7% | -10.0% | -12.2% | · | -8.7% | -1.5% | -23.2% | · | -35.1% | -35.6% | -30.6% | · | -21.0% | |
| EBITDA Margin | 85.8% | 4.3% | · | -0.25% | -12.8% | -11.5% | · | -12.7% | -4.4% | -21.5% | · | -42.8% | -39.3% | -27.1% | · | -21.9% | |
| ROA | 22.6% | 0.62% | · | 0.37% | -1.9% | -2.2% | · | -1.5% | -0.28% | -3.4% | · | -4.5% | -4.7% | -4.4% | · | -3.1% | |
| ROE | 29.4% | 0.81% | · | 0.57% | -2.9% | -3.3% | · | -2.2% | -0.42% | -4.9% | · | -5.7% | -5.9% | -5.4% | · | -3.7% | |
| ROIC | 25.7% | 0.39% | · | -0.08% | -3.4% | -3.5% | · | -4.0% | -1.6% | -7.5% | · | -7.3% | -6.8% | -5.8% | · | -4.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.4 | · | 3.0 | 3.3 | 4.1 | · | 4.1 | 4.1 | 4.3 | · | 4.7 | 4.8 | 5.2 | · | 5.5 | |
| Quick Ratio | 4.4 | 2.9 | · | 2.4 | 2.7 | 3.5 | · | 3.8 | 3.8 | 3.9 | · | 4.4 | 4.5 | 4.8 | · | 5.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 2.6 | 2.0 | · | 1.7 | 1.3 | 1.3 | · | 1.4 | 1.6 | 1.2 | · | 1.1 | 1.2 | 1.2 | · | 1.3 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.27 | $6.11 | · | $6.05 | $6.15 | $6.84 | · | $5.15 | $5.03 | $4.95 | · | $7.28 | $7.50 | $7.83 | · | $8.16 | |
| Revenue / Share | $2.47 | $2.22 | · | $1.86 | $1.60 | $1.53 | · | $1.57 | $1.77 | $1.39 | · | $1.24 | $1.31 | $1.44 | · | $1.48 | |
| Cash Flow / Share | · | $0.08 | · | · | · | $-0.48 | · | · | · | $-0.30 | · | · | · | $0.01 | · | · | |
| Cash / Share | $7.26 | $1.52 | · | $1.78 | $1.28 | $1.60 | · | $1.80 | $1.82 | $1.80 | · | $1.40 | $1.63 | $1.39 | · | $1.55 | |
| EPS (TTM) | $2.07 | $-0.16 | · | $1.28 | $1.05 | $1.12 | · | $-2.88 | $-3.11 | $-3.48 | · | $-1.67 | $-1.56 | $-1.51 | · | $-1.41 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $458M | $413M | · | $358M | $341M | $346M | · | $313M | $297M | $275M | · | $297M | $309M | $320M | · | $319M | |
| Net Income TTM | $111M | $-8M | · | $70M | $58M | $62M | · | $-153M | $-166M | $-186M | · | $-91M | $-84M | $-81M | · | $-74M | |
| Market Cap | $1.47B | $890M | · | $747M | $1.04B | $984M | · | $1.66B | $817M | $548M | · | $379M | $459M | $490M | · | $911M | |
| P/E | 13.8 | -108.5 | · | 11.4 | 18.6 | 15.8 | · | -10.8 | -5.0 | -3.0 | · | -4.2 | -5.4 | -6.1 | · | -12.1 | |
| P/S | 3.2 | 2.2 | · | 2.1 | 3.1 | 2.8 | · | 5.3 | 2.8 | 2.0 | · | 1.3 | 1.5 | 1.5 | · | 2.9 | |
| P/B | 3.4 | 2.8 | · | 2.4 | 3.2 | 2.6 | · | 6.1 | 3.1 | 2.1 | · | 1.0 | 1.1 | 1.2 | · | 2.1 | |
| P / Tangible Book | 4.0 | 3.7 | · | 3.1 | 4.1 | 3.3 | · | 8.6 | 4.5 | 3.2 | · | 1.2 | 1.4 | 1.5 | · | 2.6 | |
| P / Cash Flow | · | 205.4 | · | · | · | -37.0 | · | · | · | -35.8 | · | · | · | 730.8 | · | · | |
| Earnings Yield | 7.3% | -0.92% | · | 8.8% | 5.4% | 6.3% | · | -9.2% | -20.0% | -32.9% | · | -23.9% | -18.4% | -16.5% | · | -8.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $380M | $334M | $280M | $322M | $296M |
| Operating Margin % | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% |
| Net Income | $-21M | $53M | $-190M | $-77M | $-31M |
| Diluted EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 |
| Quick Ratio | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 241 filers · $1.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
241
Value held
$1.6B
New positions
54
Exited positions
13
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 54 (+25 vs prior Q) | 13 (-16 vs prior Q) | 77 (+6 vs prior Q) | 66 (+8 vs prior Q) | +368K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $137,219,211 | 4,814,709 | 8.74% | Shares |
| STATE STREET CORP | $70,362,453 | 2,468,858 | 4.48% | Shares |
| VANGUARD GROUP INC | $64,588,269 | 3,428,252 | 4.11% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $62,628,038 | 2,197,475 | 3.99% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56,932,113 | 1,997,618 | 3.63% | Shares |
| ARK Investment Management LLC | $55,675,622 | 1,953,531 | 3.55% | Shares |
| Boston Partners | $55,224,627 | 1,937,601 | 3.52% | Shares |
| BAMCO INC /NY/ | $55,213,791 | 1,937,326 | 3.52% | Shares |
| GAGNON SECURITIES LLC | $50,465,960 | 1,770,735 | 3.21% | Shares |
| Chevy Chase Trust Holdings, LLC | $40,966,358 | 1,437,416 | 2.61% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $37,856,083 | 1,328,037 | 2.41% | Shares |
| Ophir Asset Management Pty Ltd | $36,047,057 | 1,264,809 | 2.30% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $35,424,332 | 1,242,959 | 2.26% | Shares |
| BRAIDWELL LP | $34,787,157 | 1,220,602 | 2.22% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $33,961,455 | 1,191,630 | 2.16% | Shares |
| Blue Water Life Science Advisors, LP | $33,915,000 | 1,190,000 | 2.16% | Shares |
| Amova Asset Management Americas, Inc. | $33,848,257 | 1,188,075 | 2.16% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $33,664,351 | 1,181,077 | 2.14% | Shares |
| D. E. Shaw & Co., Inc. | $32,423,311 | 1,137,660 | 2.07% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $28,376,566 | 995,669 | 1.81% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28,201,577 | 989,529 | 1.80% | Shares |
| MORGAN STANLEY | $22,067,528 | 774,299 | 1.41% | Shares |
| Divisadero Street Capital Management, LP | $19,976,733 | 700,938 | 1.27% | Shares |
| GOLDMAN SACHS GROUP INC | $19,949,801 | 699,993 | 1.27% | Shares |
| Portolan Capital Management, LLC | $19,516,943 | 684,805 | 1.24% | Shares |
| First Eagle Investment Management, LLC | $17,057,165 | 598,497 | 1.09% | Shares |
| ROYCE & ASSOCIATES LP | $16,415,174 | 575,971 | 1.05% | Shares |
| BANK OF AMERICA CORP /DE/ | $16,296,528 | 571,808 | 1.04% | Shares |
| Gagnon Advisors, LLC | $15,586,451 | 546,893 | 0.99% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15,336,563 | 538,125 | 0.98% | Shares |
| Palo Alto Investors LP | $15,158,295 | 531,870 | 0.97% | Shares |
| Russell Investments Group, Ltd. | $14,636,172 | 513,550 | 0.93% | Shares |
| NORTHERN TRUST CORP | $13,645,745 | 478,798 | 0.87% | Shares |
| JANE STREET GROUP, LLC | $13,402,781 | 470,273 | 0.85% | Shares |
| Meridiem Capital Partners LP | $12,867,551 | 451,493 | 0.82% | Shares |
| Invesco Ltd. | $12,745,344 | 447,205 | 0.81% | Shares |
| TWO SIGMA INVESTMENTS, LP | $11,456,630 | 401,987 | 0.73% | Shares |
| Zweig-DiMenna Associates LLC | $11,081,142 | 388,812 | 0.71% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $10,684,906 | 374,909 | 0.68% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10,605,164 | 372,111 | 0.68% | Shares |
| Qube Research & Technologies Ltd | $10,540,355 | 369,837 | 0.67% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $10,446,419 | 366,541 | 0.67% | Shares |
| ArrowMark Colorado Holdings LLC | $9,648,647 | 338,549 | 0.61% | Shares |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | $8,680,000 | 500,000 | 0.55% | Shares |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8,441,700 | 296,200 | 0.54% | Shares |
| Kent Lake PR LLC | $7,997,000 | 550,000 | 0.51% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $7,643,900 | 268,207 | 0.49% | Shares |
| FMR LLC | $7,219,454 | 253,314 | 0.46% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $6,964,688 | 244,375 | 0.44% | Shares |
| Aberdeen Group plc | $6,407,627 | 224,829 | 0.41% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Merckle International GmbH ×3 filings | March 28, 2018 | · | Initial filing | Passive investment | SEC |
| Paragon Associates and Paragon Associates II Joint Venture, Paragon JV Partners, LLC, Bradbury Dyer III ×4 filings | Jan. 24, 2018 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 37 insiders · 21 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John Walter Hanna JR | President and CEO | July 16, 2026 M | 653,448 | 0 | 11 | $-7,540,215 |
| Reginald Seeto | President and Chief Executive Officer | Oct. 2, 2023 S | 479,164 | 0 | 0 | $0 |
| Keith Kennedy | CFO & COO | Sept. 12, 2026 F | 211,704 | 0 | 0 | $0 |
| Nathan Smith | Chief Financial Officer | Feb. 2, 2026 F | 79,016 | 0 | 0 | $0 |
| Abhishek Jain | Chief Financial Officer | Aug. 1, 2025 F | 319,725 | 0 | 0 | $0 |
| Ankur Dhingra | Chief Financial Officer | March 25, 2022 F | 33,146 | 0 | 0 | $0 |
| Michael Brian Bell | Chief Financial Officer | Nov. 3, 2020 M | 103,343 | 0 | 0 | $0 |
| Charles Constanti | Chief Financial Officer | Feb. 17, 2017 A | 10,000 | 0 | 0 | $0 |
| Ken Ludlum | Chief Financial Officer | Jan. 22, 2016 A | 48,000 | 0 | 0 | $0 |
| Alexander L Johnson | President of Patient and Testing Services | Aug. 21, 2024 M | 284,983 | 0 | 0 | $0 |
| Mitchell J Nelles | Chief Operating Officer | July 2, 2018 S | 85,160 | 0 | 0 | $0 |
| Jessica Meng | Chief Commercial Officer | Sept. 12, 2026 F | 161,599 | 0 | 0 | $0 |
| Jeffrey Adam Novack | Secretary and General Counsel | Aug. 5, 2026 S | 106,075 | 0 | 7 | $-452,796 |
| Abraham Ronai | Officer | Sept. 20, 2023 A | 515,986 | 0 | 0 | $0 |
| Sasha King | Chief Marketing Officer | Aug. 9, 2022 A | 78,420 | 0 | 0 | $0 |
| James P Yee | Chief Medical Officer | July 1, 2019 M | 42,045 | 0 | 0 | $0 |
| John Joseph Sninsky | Chief Scientific Officer | Jan. 29, 2018 F | 22,309 | 0 | 0 | $0 |
| Anders Karlsson | Chief Commercial Officer | Jan. 19, 2018 A | 9,638 | 0 | 0 | $0 |
| Todd Whitson | Chief Commercial Officer | Feb. 17, 2017 A | 20,000 | 0 | 0 | $0 |
| Joshua Defonzo | Chief Commercial Officer | Jan. 22, 2016 A | 11,000 | 0 | 0 | $0 |
| Matthew J. Meyer | Chief Business Officer | Jan. 22, 2016 A | 23,025 | 0 | 0 | $0 |
| Hannah Valantine | Director | July 16, 2026 M | 36,686 | 0 | 3 | $-1,319,814 |
| Suresh Gunasekaran | Director | June 12, 2026 A | 37,248 | 0 | 0 | $0 |
| Richard Bryan Riggsbee | Director | June 12, 2026 A | 39,312 | 0 | 0 | $0 |
| Fred Cohen | Director | June 12, 2026 A | 165,060 | 0 | 0 | $0 |
| Peter Maag | Director | July 7, 2025 S | 308,846 | 0 | 0 | $0 |
| William A Hagstrom | Director | June 11, 2025 M | 53,979 | 0 | 0 | $0 |
| Grace Colon | Director | June 16, 2023 A | 23,708 | 0 | 0 | $0 |
| Ralph Snyderman | Director | Oct. 4, 2022 A | 58,177 | 0 | 0 | $0 |
| Amy Abernethy | Director | Jan. 22, 2019 M | 15,837 | 0 | 0 | $0 |
| Douglas S Miller | Director | April 1, 2017 A | 17,695 | 0 | 0 | $0 |
| Neil Gagnon | 10% owner | Oct. 31, 2018 S | 867,744 | 0 | 0 | $0 |
| George Bickerstaff | · | Aug. 5, 2026 S | 134,061 | 0 | 1 | $-925,600 |
| Michael Goldberg | · | Aug. 4, 2026 S | 61,738 | 0 | 1 | $-2,103,582 |
| Christine Cournoyer | · | Aug. 4, 2026 S | 42,943 | 0 | 1 | $-751,040 |
| Arthur A Torres | · | May 15, 2026 S | 38,665 | 0 | 2 | $-214,650 |
| BYERS BROOK H | · | July 1, 2016 A | 21,912 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 44 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 4.30% | 1,531,579 NS | July 31, 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2.68% | 42,385 NS | July 31, 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2.09% | 91,120 SH | Oct. 2, 2026 | Daily |
| SAWS · ETF Series Solutions | 1.43% | 2,554 NS | July 31, 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1.07% | 88,521 NS | July 31, 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0.95% | 229,825 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.61% | 174,097 SH | Sept. 11, 2026 | Daily |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.57% | 34,673 SH | Oct. 2, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.48% | 18,953 SH | Oct. 2, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.34% | 38,851 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.17% | 356,183 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.17% | 482,280 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.16% | 63,788 SH | Oct. 2, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.14% | 42,483 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.12% | 69,521 SH | Sept. 11, 2026 | Daily |
| PKW · Invesco Exchange-Traded Fund Trust | 0.12% | 30,292 SH | Oct. 2, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.10% | 531 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.09% | 54,986 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.08% | 1,317,079 SH | Sept. 11, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.08% | 19,899 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.07% | 24,512 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.05% | 172,629 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 295,088 SH | Aug. 19, 2026 | Daily |
| ISCG · iShares Trust | 0.04% | 7,437 SH | Sept. 11, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.03% | 4,860 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 20,688 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.02% | 2,782 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 591,907 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 131,033 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 136,968 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 4,263 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3,171 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 710 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 4,121 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 76,915 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 10,288 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 12,572 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 13,233 SH | Sept. 8, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 12,950 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,554,868 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4,148 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 2,150 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 5,217 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 60,988 SH | Sept. 11, 2026 | Daily |
CDNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$61.00
-11.1%
5 38.5%
Strong Buy
4 30.8%
Buy
4 30.8%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-02Mean target $58.83 -14.2%
Now
Current price $68.58
Low$46.00
Mean$58.83
High$74.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026